Inhibition of VEGF-Dependent Multistage Carcinogenesis by Soluble EphA Receptors

This publication has 26 references indexed in Scilit:

• Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo
  Oncogene, 2002
• Clinical translation of angiogenesis inhibitors
  Nature Reviews Cancer, 2002
• Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
  Science, 2002
• The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization
  Oncogene, 2000
• Regulated Cleavage of a Contact-Mediated Axon Repellent
  Science, 2000
• Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in Mice
  Science, 1999
• THE EPHRINS AND EPH RECEPTORS IN NEURAL DEVELOPMENT
  Annual Review of Neuroscience, 1998
• Ephrins and their receptors: a repulsive topic?
  Cell and tissue research, 1997
• Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models
  European Journal Of Cancer, 1996
• Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
  Published by Elsevier ,1996